About This Project
BBRI and Los Angeles VA Medical Center
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.
Browse Other Projects on Experiment
Northern koala populations have declined rapidly in the last two decades and localised extinctions are predicted...
Thermolyze: A Temperature Controlled Kill-Switch for Containment of Pathogenic Bacteria in Research Labs
We will engineer a temperature-controlled kill switch to be used in pathogenic or genetically modified bacteria...